Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz


1. 1,3-di(4-amidino-2-bromophenoxy)propane Di-2-hydroxyethanesulfonate
2. Brolene
3. Brulidine
4. Dibromopropamidine
5. Dibromopropamidine Isethionate
6. Dibrompropamidine
7. Dibrompropamidine Hydrochloride
8. Dibrompropamidine Isethionate
9. Dibropropamidine Isethionate
1. 614-87-9
2. Dibrompropamidine Diisetionate
3. 4,4'-(propane-1,3-diylbis(oxy))bis(3-bromobenzimidamide) Bis(2-hydroxyethanesulfonate)
4. Dibromopropamidine Diisethionate
5. Dibromopropamidine Isethionate
6. Dibrompropamidine Isethionate
7. 12y597mo62
8. 3-bromo-4-[3-(2-bromo-4-carbamimidoylphenoxy)propoxy]benzenecarboximidamide;2-hydroxyethanesulfonic Acid
9. Nsc-33424
10. Nsc-528031
11. Unii-12y597mo62
12. Brolene (tn)
13. Einecs 210-399-5
14. Nsc 33424
15. Nsc 528031
16. Schembl2471251
17. Ex-a4352
18. Mfcd04112915
19. Akos024464485
20. Dibrompropamidine Di-isethionate
21. Dibrompropamidine For System Suitability
22. Dibromopropamidine Isethionate [mi]
23. Dibrompropamidine Isetionate [mart.]
24. Dibrompropamidine Isetionate [who-dd]
25. Dibromopropamidine Diisethionate [inci]
26. D07813
27. Dibrompropamidine Diisetionate [ep Monograph]
28. Q27251446
29. 4,4'-(propane-1,3-diylbis(oxy))bis(3-bromobenzimidamide) Bis(2-hydroxyethane-1-sulfonate)
30. 4,4'-(propane-1,3-diylbis(oxy))bis(3-bromobenzimidamide)bis(2-hydroxyethanesulfonate)
31. 4,4-(propane-1,3-diylbis(oxy))bis(3-bromobenzimidamide) Bis(2-hydroxyethanesulfonate)
32. 4,4'-(1,3-propanediylbis(oxy))bis(3-bromo-benzenecarboximidamide, Bis(2-hydroxyethanesulfonate)
33. 4,4'-(1,3-propanediylbis(oxy))bis(3-bromo-benzenecarboximidamide, Bis(2-hydroxyethanesulphonate)
34. Ethanesulfonic Acid, 2-hydroxy-, Compd. With 4,4'-(1,3-propanediylbis(oxy))bis(3-bromobenzenecarboximidamide) (2:1)
35. Ethanesulfonic Acid, 2-hydroxy-, Compd. With 4,4'-(trimethylenedioxy)bis(3-bromobenzamidine) (2:1)
| Molecular Weight | 722.4 g/mol |
|---|---|
| Molecular Formula | C21H30Br2N4O10S2 |
| Hydrogen Bond Donor Count | 8 |
| Hydrogen Bond Acceptor Count | 12 |
| Rotatable Bond Count | 12 |
| Exact Mass | 721.97496 g/mol |
| Monoisotopic Mass | 719.97701 g/mol |
| Topological Polar Surface Area | 284 Ų |
| Heavy Atom Count | 39 |
| Formal Charge | 0 |
| Complexity | 543 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
Anti-Infective Agents, Local
Substances used on humans and other animals that destroy harmful microorganisms or inhibit their activity. They are distinguished from DISINFECTANTS, which are used on inanimate objects. (See all compounds classified as Anti-Infective Agents, Local.)
ABOUT THIS PAGE
44
PharmaCompass offers a list of Dibrompropamidine Isetionate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Dibrompropamidine Isetionate manufacturer or Dibrompropamidine Isetionate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Dibrompropamidine Isetionate manufacturer or Dibrompropamidine Isetionate supplier.
A Brolene manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Brolene, including repackagers and relabelers. The FDA regulates Brolene manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Brolene API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Brolene manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Brolene supplier is an individual or a company that provides Brolene active pharmaceutical ingredient (API) or Brolene finished formulations upon request. The Brolene suppliers may include Brolene API manufacturers, exporters, distributors and traders.
click here to find a list of Brolene suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
Brolene Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Brolene GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Brolene GMP manufacturer or Brolene GMP API supplier for your needs.
A Brolene CoA (Certificate of Analysis) is a formal document that attests to Brolene's compliance with Brolene specifications and serves as a tool for batch-level quality control.
Brolene CoA mostly includes findings from lab analyses of a specific batch. For each Brolene CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Brolene may be tested according to a variety of international standards, such as European Pharmacopoeia (Brolene EP), Brolene JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Brolene USP).